Stay updated on Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Sign up to get notified when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.

Latest updates to the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page
- Check7 days agoChange DetectedThe page has been replaced with a 403 Forbidden error page, effectively blocking access to the study record details. Visible additions include a 403 header and related HTML, signaling an access restriction rather than new study information.SummaryDifference19%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded a note showing the 2019 ( U.S. NIH Grant/Contract ) in the study identifiers, and updated the page version to v3.6.6 (replacing v3.6.5).SummaryDifference0.1%

- Check50 days agoChange DetectedRevision tag in the page footer updated from v3.6.4 to v3.6.5, indicating a minor system update. This change does not affect the study details or other user-facing information.SummaryDifference0.0%

- Check64 days agoChange DetectedThe additions show a new revision tag, Revision: v3.6.4, and the deletions remove the previous tag Revision: v3.6.3. This indicates a new deployment of the page; the change is technical rather than content-related.SummaryDifference0.0%

- Check86 days agoChange Detected- Revision label updated from v3.6.2 to v3.6.3 on the page. This indicates a minor update to the study page content display.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page's revision label was updated to v3.6.2, indicating a platform or template update rather than changes to the study data. No study content, results, or eligibility information appear to be altered.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.